alantolactone has been researched along with Alloxan Diabetes in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Ling, Y; Wang, X; Zhu, Y | 1 |
1 other study(ies) available for alantolactone and Alloxan Diabetes
Article | Year |
---|---|
Alantolactone mitigates renal injury induced by diabetes via inhibition of high glucose-mediated inflammatory response and macrophage infiltration.
Topics: Animals; Anti-Inflammatory Agents; Cell Adhesion; Cell Line; Cytokines; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Kidney; Kidney Function Tests; Lactones; Macrophages, Peritoneal; Mice, Inbred C57BL; Rats; Sesquiterpenes, Eudesmane | 2020 |